• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A comparative overview of COVID-19, MERS and SARS: Review article.新型冠状病毒病、中东呼吸综合征和严重急性呼吸综合征的比较概述:综述文章。
Int J Surg. 2020 Sep;81:1-8. doi: 10.1016/j.ijsu.2020.07.032. Epub 2020 Jul 26.
2
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2),一种新出现的病原体:概述。
Pathog Dis. 2020 Aug 1;78(6). doi: 10.1093/femspd/ftaa042.
3
A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).《关于〈2019年冠状病毒病、中东呼吸综合征和严重急性呼吸综合征的比较概述:综述文章〉的评论》(《国际外科学杂志》2020年;81卷:第1 - 8页)
Int J Surg. 2020 Nov;83:28-29. doi: 10.1016/j.ijsu.2020.08.049. Epub 2020 Sep 11.
4
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.洛匹那韦疗法治疗严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒的系统评价——为新型冠状病毒病治疗方案提供参考。
J Med Virol. 2020 Jun;92(6):556-563. doi: 10.1002/jmv.25729. Epub 2020 Mar 12.
5
Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features.儿童冠状病毒感染:从SARS、MERS到COVID-19,关于流行病学和临床特征的叙述性综述
Acta Biomed. 2020 Sep 7;91(3):e2020032. doi: 10.23750/abm.v91i3.10294.
6
COVID-19, SARS and MERS: are they closely related?新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征:它们有何关联?
Clin Microbiol Infect. 2020 Jun;26(6):729-734. doi: 10.1016/j.cmi.2020.03.026. Epub 2020 Mar 28.
7
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.从 SARS 和 MERS 到 COVID-19:三种高致病性人冠状病毒引起的严重急性呼吸道感染的简要总结和比较。
Respir Res. 2020 Aug 27;21(1):224. doi: 10.1186/s12931-020-01479-w.
8
Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.新型冠状病毒 SARS-CoV-2、SARS-CoV 和中东呼吸综合征冠状病毒(MERS-CoV)相关病毒性肺炎的研究:文献综述。
APMIS. 2020 Jun;128(6):423-432. doi: 10.1111/apm.13047.
9
Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.冠状病毒疾病与妊娠:新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征
Przegl Epidemiol. 2020;74(2):276-289. doi: 10.32394/pe.74.21.
10
COVID-19: Look to the Future, Learn from the Past.COVID-19:放眼未来,汲取既往经验。
Viruses. 2020 Oct 29;12(11):1226. doi: 10.3390/v12111226.

引用本文的文献

1
Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury.免疫调节:对抗SARS-CoV-2诱导的心肌损伤的关键。
Front Immunol. 2025 May 14;16:1561946. doi: 10.3389/fimmu.2025.1561946. eCollection 2025.
2
Surveillance System for Infectious Disease Prevention and Management: Direction of Korea's Infectious Disease Surveillance System.传染病预防与管理监测系统:韩国传染病监测系统的发展方向
J Korean Med Sci. 2025 Mar 3;40(8):e108. doi: 10.3346/jkms.2025.40.e108.
3
Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development.新型冠状病毒变异株刺突蛋白突变及抗体研发的研究进展
Front Immunol. 2024 Nov 18;15:1407149. doi: 10.3389/fimmu.2024.1407149. eCollection 2024.
4
Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor.鉴定南非植物源生物活性化合物作为针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体的潜在抑制剂。
Pharmaceuticals (Basel). 2024 Jun 22;17(7):821. doi: 10.3390/ph17070821.
5
Insights into the Activation of Unfolded Protein Response Mechanism during Coronavirus Infection.冠状病毒感染期间未折叠蛋白反应机制激活的见解
Curr Issues Mol Biol. 2024 May 5;46(5):4286-4308. doi: 10.3390/cimb46050261.
6
Development of Fluorescence-Based Assays for Key Viral Proteins in the SARS-CoV-2 Infection Process and Lifecycle.用于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染过程和生命周期中关键病毒蛋白的基于荧光的检测方法的开发。
Int J Mol Sci. 2024 Mar 1;25(5):2850. doi: 10.3390/ijms25052850.
7
Estimating the Epidemic Size of Superspreading Coronavirus Outbreaks in Real Time: Quantitative Study.实时估计超级传播冠状病毒暴发的流行规模:定量研究。
JMIR Public Health Surveill. 2024 Feb 12;10:e46687. doi: 10.2196/46687.
8
Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays.使用RNA双链解旋测定法检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎nsp13 R392C变体的活性和抑制作用。
SLAS Discov. 2024 Apr;29(3):100145. doi: 10.1016/j.slasd.2024.01.006. Epub 2024 Feb 1.
9
The Effect of Social Isolation, Loneliness, and Physical Activity on Depressive Symptoms of Older Adults during COVID-19: A Moderated Mediation Analysis.社交隔离、孤独感和身体活动对 COVID-19 期间老年人抑郁症状的影响:一个有调节的中介分析。
Int J Environ Res Public Health. 2023 Dec 23;21(1):26. doi: 10.3390/ijerph21010026.
10
Early detection of deterioration in COVID-19 patients by continuous ward respiratory rate monitoring: a pilot prospective cohort study.通过持续监测病房呼吸频率早期发现新冠病毒疾病患者病情恶化:一项前瞻性队列试点研究
Front Med (Lausanne). 2023 Oct 31;10:1243050. doi: 10.3389/fmed.2023.1243050. eCollection 2023.

本文引用的文献

1
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.SARS-CoV-2 和 SARS-CoV 的比较嗜性、复制动力学和细胞损伤特征分析及其对 COVID-19 临床表现、传染性和实验室研究的影响:一项观察性研究。
Lancet Microbe. 2020 May;1(1):e14-e23. doi: 10.1016/S2666-5247(20)30004-5. Epub 2020 Apr 21.
2
Determinants of COVID-19 disease severity in patients with cancer.癌症患者 COVID-19 疾病严重程度的决定因素。
Nat Med. 2020 Aug;26(8):1218-1223. doi: 10.1038/s41591-020-0979-0. Epub 2020 Jun 24.
3
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective.COVID-19 大流行期间原发性肝脏恶性肿瘤的管理:多学科角度的风险缓解建议。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):765-775. doi: 10.1016/S2468-1253(20)30182-5. Epub 2020 Jun 6.
4
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study.围手术期 SARS-CoV-2 感染患者的死亡率和肺部并发症:一项国际队列研究。
Lancet. 2020 Jul 4;396(10243):27-38. doi: 10.1016/S0140-6736(20)31182-X. Epub 2020 May 29.
5
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
6
Cancer in the time of COVID-19: expert opinion on how to adapt current practice.COVID-19 时期的癌症:专家关于如何调整当前实践的意见。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00959-2020. Print 2020 May.
7
The COVID-19 vaccine development landscape.2019冠状病毒病疫苗的研发情况。
Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5.
8
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.雪貂、猫、狗和其他驯养动物对 SARS-CoV-2 的易感性。
Science. 2020 May 29;368(6494):1016-1020. doi: 10.1126/science.abb7015. Epub 2020 Apr 8.
9
CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China.COVID-19 的 CT 影像学改变:中国西南部多中心研究。
J Transl Med. 2020 Apr 6;18(1):154. doi: 10.1186/s12967-020-02324-w.
10
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.

新型冠状病毒病、中东呼吸综合征和严重急性呼吸综合征的比较概述:综述文章。

A comparative overview of COVID-19, MERS and SARS: Review article.

机构信息

Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

出版信息

Int J Surg. 2020 Sep;81:1-8. doi: 10.1016/j.ijsu.2020.07.032. Epub 2020 Jul 26.

DOI:10.1016/j.ijsu.2020.07.032
PMID:32730205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7382925/
Abstract

Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), a third, highly pathogenic coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appearing at end of 2019 led to a pandemic, increased panic and attracted global attention. This review analyzes the epidemiology, etiology, clinical characteristics, treatment and sequelae of the severe acute respiratory syndrome (SARS), the Middle East respiratory syndrome (MERS) and the 2019 novel coronavirus disease (COVID-19) to help provide direction for further studies that can help understand COVID-19.

摘要

继严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV)之后,第三种高致病性冠状病毒,即 2019 年底出现的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引发了大流行,加剧了恐慌,并引起了全球关注。本综述分析了严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS)和 2019 年新型冠状病毒病(COVID-19)的流行病学、病因、临床特征、治疗和后遗症,以帮助为进一步的研究提供方向,有助于了解 COVID-19。